Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 213 for “"VLPs"”.

  1. Developing Virus-Like Particles (VLPs) and Heterologous VLPs Vaccines for Epizootic Hemorrhagic Disease Virus (EHDV) Serotypes

    … (IBAV). In this study, Virus-Like Particles (VLPs) of EHDV-1 and heterologous VLPs of EHDV-2 were generated using baculovirus multigene expression system for the synthesis of the two outer and two inner capsid proteins, essential for the formation of VLPs. The assembly of EHDV-1 recombinant …

    lshtm Repository record for Developing Virus-Like Particles (VLPs) and Heterologous VLPs Vaccines for Epizootic Hemorrhagic Disease Virus (EHDV) Serotypes (opens in a new tab) Download PDF for Developing Virus-Like Particles (VLPs) and Heterologous VLPs Vaccines for Epizootic Hemorrhagic Disease Virus (EHDV) Serotypes (opens in a new tab)

  2. EFFICACY OF MIXED MS2-L2 VLPS AGAINST SIX HPV TYPES AND THE DEVELOPMENT & EVALUATION OF VIRAL STRUCTURAL PROTEINS FOR ASSEMBLY INTO VLPS

    Virus-like particles (VLPs) are empty viral shells derived from the expression of viral structural proteins such as capsid (coat) proteins in a suitable host cell. They are morphologically and structurally similar to viruses from which the coat proteins were derived, except for the fact that they …

    mtu Repository record for EFFICACY OF MIXED MS2-L2 VLPS AGAINST SIX HPV TYPES AND THE DEVELOPMENT & EVALUATION OF VIRAL STRUCTURAL PROTEINS FOR ASSEMBLY INTO VLPS (opens in a new tab)

  3. Using QB VLPS to package, protect, and deliver in vivo produced RNAS

    This project focuses on Using Qβ VLPs to package, protect, and deliver recombinantly produced RNAs. The ultimate goal is to develop an RNA interference (RNAi) delivery platform to inhibit gene expression that is spontaneously assembling and scalable for potential medical applications. Preliminary …

    gatech Repository record for Using QB VLPS to package, protect, and deliver in vivo produced RNAS (opens in a new tab)

  4. Virus-Like Particles (VLPs) platform for the development of an effective melanoma vaccine

    … personalized melanoma vaccine platform based on VLPs and copper-free click chemistry, enabling bedside production of personalized cancer vaccines. There is currently a debate in the field whether cancer-specific, non-mutated germ-line epitopes or mutated neo-epitopes are more powerful antigens …

    oxford Repository record for Virus-Like Particles (VLPs) platform for the development of an effective melanoma vaccine (opens in a new tab)

  5. The Immunogenicity of Plant-produced Human Papillomavirus (HPV) Virus-like particles (VLPs) in Mice

    … can self-assemble into virus-like particles (VLPs) that are structurally like native virions, which is the foundation on which commercially available vaccines have been developed. There are 3 commercially available HPV vaccines that are effective at preventing HPV infections, but are …

    cape-town Repository record for The Immunogenicity of Plant-produced Human Papillomavirus (HPV) Virus-like particles (VLPs) in Mice (opens in a new tab)

  6. Generation and Characterization of Dual-Fluorescent Influenza Virus-like Particles (VLPs) in Insect Cells

    … production of influenza virus-like particles (VLPs). The goal is to successfully produce fluorescent influenza particles that behave similarly to native particles and that allow the purification of viral particles. Four different genetic constructs were investigated for the expression of …

    waterloo Repository record for Generation and Characterization of Dual-Fluorescent Influenza Virus-like Particles (VLPs) in Insect Cells (opens in a new tab)

  7. Safety and Protective Efficacy of Respiratory Syncytial Virus-Like Particles (RSV VLPs) in a Murine Model

    … (MPLA)-adjuvanted RSV virus-like particles (RSV VLPs) that express the F and G surface proteins and the M matrix protein, in a murine model. F is a crucial protein in RSV vaccine development because it contains neutralizing epitopes that can be targeted by neutralizing antibodies. We conducted an …

    hawaii Repository record for Safety and Protective Efficacy of Respiratory Syncytial Virus-Like Particles (RSV VLPs) in a Murine Model (opens in a new tab)

  8. The Glycobiology of SARS-CoV-2 Virus and Development of Virus-Like-Particles (VLPs) for mRNA Delivery

    … a number of SARS-CoV-2 virus-like-particles (VLPs) systems, greatly facilitating the basic biology studies of the virus. Moreover, these VLPs can be exploited for the targeted delivery of transgene into specific cell type, given the expression of specific viral glycoprotein on the VLPs …

    buffalo Repository record for The Glycobiology of SARS-CoV-2 Virus and Development of Virus-Like-Particles (VLPs) for mRNA Delivery (opens in a new tab)

  9. Development of Virus-like particles (VLPs) Based Vaccines Against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Porcine Epidemic Diarrhea Virus (PEDV)

    Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine epidemic diarrhea virus (PEDV) are two of the most prevalent swine pathogens that have impacted the global swine industry for decades. Both are RNA viruses with increasing heterogeneity over the years, making a vaccine solution …

    vt Repository record for Development of Virus-like particles (VLPs) Based Vaccines Against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Porcine Epidemic Diarrhea Virus (PEDV) (opens in a new tab)

  10. Design of hybrid retroviral/synthetic gene delivery vectors

    … Murine Leukemia Virus (MLV) -like particles (M-VLPs). M-VLPs are essentially intact viruses lacking the envelope protein most necessary for transfection, thus making them inactive. Both chitosan and liposomes composed of DOTAP, DOPE and cholesterol electrostatically associated with M-VLPs …

    uiuc Repository record for Design of hybrid retroviral/synthetic gene delivery vectors (opens in a new tab)

  11. Modelinės priešvėžinės vakcinos konstravimas panaudojant į virusus panašias daleles /

    … protein VP1 based chimeric virus-like particles (VLPs) harboring CTL epitopes for anticancer vaccine development is presented. The objective of this study was to investigate the potential of recombinant HaPyV VP1 based VLPs for anticancer vaccine generation in model systems, including …

    vilnius Repository record for Modelinės priešvėžinės vakcinos konstravimas panaudojant į virusus panašias daleles / (opens in a new tab)

  12. Generation of anticancer vaccine based on virus-like particles /

    … protein VP1 based chimeric virus-like particles (VLPs) harboring CTL epitopes for anticancer vaccine development is presented. The objective of this study was to investigate the potential of recombinant HaPyV VP1 based VLPs for anticancer vaccine generation in model systems, including …

    vilnius Repository record for Generation of anticancer vaccine based on virus-like particles / (opens in a new tab)

  13. Morphology of Nipah virus-like particles studied by super-resolution microscopy

    … of viral proteins. Virus-like particles (VLPs) are particles that contain partial or complete viral proteins without the existence of viral genomes. For highly contagious and fatal viruses, such as the Nipah virus (NiV), VLPs are widely-used research surrogates to study functions of viral …

    ubc Repository record for Morphology of Nipah virus-like particles studied by super-resolution microscopy (opens in a new tab) Download PDF for Morphology of Nipah virus-like particles studied by super-resolution microscopy (opens in a new tab)

  14. Intranasal Immunization of Pigs with Porcine Reproductive and Respiratory Syndrome Virus like Particles Plus 2’, 3’ –cGamp Vaccigrade™ Adjuvant Exacerbates Viremia After Virus Challenge

    … cross-protection. A virus-like particles (VLPs) vaccine is made up of key PRRSV structural proteins, which could be cross protective among the different strains. We tested PRRSV VLPs as a vaccine candidate with a 2’, 3’-cGAMP VacciGradeTM adjuvant against pigs infected with PRRSV after …

    sdstate Repository record for Intranasal Immunization of Pigs with Porcine Reproductive and Respiratory Syndrome Virus like Particles Plus 2’, 3’ –cGamp Vaccigrade™ Adjuvant Exacerbates Viremia After Virus Challenge (opens in a new tab)

  15. Betapolyomavirus securanorvegicus VP1 baltymo mutantų sintezės mielėse efektyvumo tyrimas /

    … capable of gathering into virus-like particles (VLPs). VLP are nanostructures that lack of genetic material and have identical structure to viruses. Previous researches have demonstrated the effect of Hamster polyomavirus (HaPyV) VLPs. It was shown that HaPyV VLPs are able to cause long lasting …

    vilnius Repository record for Betapolyomavirus securanorvegicus VP1 baltymo mutantų sintezės mielėse efektyvumo tyrimas / (opens in a new tab)

  16. An Investigation into the Use of a Plant-Expressed Virus-Like Particle as an Oral Vaccine Candidate

    Abstract Plant-expressed virus-like particles (VLPs) could offer an alternative method for the oral delivery of vaccines. VLPs' robustness, combined with their compartmentalisation within the plant cells, should favour their stability in the harsh gastro-intestinal (GI) environment. In the small …

    east-anglia Download PDF for An Investigation into the Use of a Plant-Expressed Virus-Like Particle as an Oral Vaccine Candidate (opens in a new tab)

  17. C. elegans Germline Defense Against Retrotransposons

    … nor has the presence of virus-like particles (VLPs) been previously reported in germ cells. Retroelements that infect non-dividing cells must access the nucleus via nuclear pores, and in nematode germ cells the majority of nuclear pores are clustered under ribonucleoprotein particles called P …

    washington Repository record for C. elegans Germline Defense Against Retrotransposons (opens in a new tab)

  18. Exploration, Modification, and Assessment of Structural Proteins from Bacteriophages ΦIN93, AP205, and MS2 for Assembly into Virus-Like Particles

    … self-assemble into virus-like particles (VLPs). VLPs are good platforms for displaying foreign antigens for vaccine design and for the delivery of drugs. VLPs derived from thermostable viruses do not have pre-existing antibodies in humans and animals; thus, they would have broad …

    ttu Repository record for Exploration, Modification, and Assessment of Structural Proteins from Bacteriophages ΦIN93, AP205, and MS2 for Assembly into Virus-Like Particles (opens in a new tab) Embargoed until 2026-12-01

  19. A proteomic approach for studying LTR retrotransposon host factors in saccharomyces cerevisae

    … of Ty proteins, virus-like particles (VLPs) assemble in the cytoplasm. VLPs contain Ty RNA and enzymes surrounded by a capsid shell. Specific cellular tRNAs are also packaged within VLPs and serve as primers for reverse transcription of Ty element RNA into dsDNA. Ty dsDNA enters the …

    umkc Repository record for A proteomic approach for studying LTR retrotransposon host factors in saccharomyces cerevisae (opens in a new tab)

  20. Characterization of virus-like particles from the BEVS platform with a special focus on gradient ultracentrifugation

    … Syndrome (SARS) Virus-Like-Particles (VLPs) may be suitable as vaccine candidates. Early indications were that a SARS-VLP could be generated based on a universal betacoronavirus sequence using only Spike, Envelope and Membrane structural proteins. This process involved the generation of …

    waterloo Repository record for Characterization of virus-like particles from the BEVS platform with a special focus on gradient ultracentrifugation (opens in a new tab)

Page 1 of 11